ClinicalTrials.Veeva

Menu

Swiss Kidney Stone Cohort (SKSC)

T

The Swiss National Centre of Competence in Research Kidney Control of Homeostasis

Status

Unknown

Conditions

Kidney Stone

Study type

Observational

Funder types

Other

Identifiers

NCT01990027
KEK-2013-0330

Details and patient eligibility

About

The SKSC is a continuous database with the objective of a standardized diagnosis and monitoring of patients with kidney stones as well as the establishment of a Biobank.

Full description

The objective of this study is multi-site, standardized observation and characterization of kidney stone patients.

Furthermore, an adequate structure should be established for the execution of studies with kidney stone patients, in order to then, if necessary, develop recommendations for useful monitoring or prophylactic measures, as well as new treatment options for kidney stone patients.

A control group of 250 stone-free volunteers matching patients cohort participants for sex and age started recruitment in October 2017 and will serve the purpose of comparison in future studies.

Enrollment

1,250 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

For SKSC Patients Group:

Inclusion Criteria:

Only patients that meet all of the following inclusion criteria can be included in this study:

  • Signed Declaration of informed consent
  • Male or female
  • Recurrent kidney stone episodes (more than 1) or an individual kidney stone episode with one or several of the following risk factors:
  • The first manifestation at the a minimum age of 25
  • Positive family history
  • Non-calcium oxalate stones
  • Gastrointestinal disorders (e.g. gastric bypass surgery, inflammatory bowel disease, malabsorption etc.)
  • Osteoporosis
  • Nephrocalcinosis
  • Single kidneyness
  • Currently pregnant
  • Gout
  • Metabolic syndrome ( Diabetes Mellitus type I and II )
  • Residual calculi (at least 3 months after the therapy)
  • Bilateral or multiple stones
  • Chronic urinary tract infection
  • Chronic renal failure (eGFR lower than 60 ml/min.)
  • Kidney transplant

Exclusion Criteria:

Patients with at least one of the following exclusion criteria may not take part in this study.

  • Not signed Informed Consent form
  • Age below 18 years old

For SKSC Control Group

Inclusion criteria:

  • Signed Declaration of informed consent
  • Male or female
  • Kidney-stone free (screening verification by low-dose CT-scan)

Exclusion criteria:

  • Not signed Informed Consent form
  • Age below 18 years old
  • Pregnancy
  • History of kidney stones
  • Low-dose CT-scan positive for kidney stones during screening phase

Trial design

1,250 participants in 2 patient groups

SKSC Patients group
Description:
A group a 1000 subjects affected by kidney stone as described in the eligibility criteria will be recruited in the period 2014-2024 and the same exams will be repeated for each participants for a period of 3 years. No intervention will be undertaken.
SKSC Control group
Description:
A group of 250 stone-free participants will be recruited and analysed with the same protocol as the patients but in a single visit. This group will be used for comparison with the patients group in future studies. No intervention will be undertaken.

Trial contacts and locations

6

Loading...

Central trial contact

Olivier Bonny, MD-PhD; Carsten Wagner, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems